Thanks to CT-SCOUTTM you can identify the studies running at your site that could be worth considering for a patient. No need to know or remember all studies criteria: CT-SCOUTTM powerful algorithm will efficiently support you in identifying the potential appropriate studies. CT-SCOUTTM can also help you coordinate the research activities with your colleagues
Our web and mobile application exclusively designed for investigators, with its easy-to-use questionnaire.
Minimize the administrative burden and redundancy that keeps you and your site staff from focusing on clinical research and patient care.
Help your patients expand access to clinical trials by integrating CT-SCOUT
Receive alerts when a patient is identified and track your patients in a decentralized manner
January 30, 2025
MedtechDive Artificial intelligence was a topic of focus for the medical device industry in 2024. Companies including GE Healthcare, Medtronic and Dexcom touted new AI features, and others like Stryker and Quest Diagnostics added AI assets through M&A. Meanwhile, conversations about regulations and generative AI, models that are trained to create new data including images and text, dominated medtech conferences. The Food and Drug Administration recently […]
January 30, 2025
BioPharm International FDA published a final guidance on Jan. 2, 2025 for those interested in participating in the agency’s Advanced Manufacturing Technologies Designation Program, which was developed to facilitate drugs manufactured using advanced manufacturing technologies (AMTs). The guidance, Advanced Manufacturing Technologies Designation Program, is the final version of the draft document issued on Dec. 13, 2023. […]
January 30, 2025
Applied Clinical Trials Online Medable has shared new data from the Tufts Center for the Study of Drug Development (CSDD)’s PACT Consortium linking decentralized clinical trial (DCT) approaches to a higher rate in participation across multiple demographic groups. The new research shows that a more strategic implementation of DCT elements, combined with increased regulatory oversight, […]